Clinical Trial Update: Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating continuous infusion gemcitabine in adults with advanced/metastatic cancer. The source lists the trial status as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Advocate Lutheran General Hospital | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: UNKNOWN